stars 1 stars 2 stars 3

Founded in 2020, Immunocan Biotech Co., Ltd. is a biotechnology company dedicated to building antibody drug discovery platforms using innovative gene editing technology. Our goal is to empower global antibody drug R&D with proprietary gene-edited animal platform generating human and alpaca antibody, suitable for different drug discovery scenarios.

Immunocan Questions

Yu Zhang is the Vice President of Business Development of Immunocan.

7 people are employed at Immunocan.

Immunocan is based in Cambridge, Massachusetts.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users